SPINA, Valeria Romina
 Distribuzione geografica
Continente #
NA - Nord America 912
EU - Europa 874
AS - Asia 211
Continente sconosciuto - Info sul continente non disponibili 10
SA - Sud America 2
Totale 2.009
Nazione #
US - Stati Uniti d'America 909
IE - Irlanda 281
SE - Svezia 165
DE - Germania 161
UA - Ucraina 96
IT - Italia 90
CN - Cina 75
IN - India 50
HK - Hong Kong 47
FI - Finlandia 45
SG - Singapore 27
GB - Regno Unito 19
EU - Europa 10
IR - Iran 10
BE - Belgio 4
AL - Albania 3
CA - Canada 3
CH - Svizzera 2
CL - Cile 2
FR - Francia 2
AE - Emirati Arabi Uniti 1
BG - Bulgaria 1
CZ - Repubblica Ceca 1
ES - Italia 1
GR - Grecia 1
NL - Olanda 1
RU - Federazione Russa 1
TR - Turchia 1
Totale 2.009
Città #
Dublin 281
Jacksonville 188
Chandler 104
Dearborn 90
Wilmington 84
Piemonte 48
Hong Kong 46
Ann Arbor 36
Lawrence 33
Princeton 33
Beijing 31
Boardman 28
Bremen 24
San Mateo 24
Ashburn 19
Singapore 14
Andover 13
Grafing 12
Hefei 12
Düsseldorf 8
Nanjing 7
Woodbridge 7
Houston 5
Kunming 5
Leawood 5
Norwalk 5
Brussels 4
Casalecchio Di Reno 4
Florence 4
Zanjan 4
Berlin 3
Guangzhou 3
Milan 3
Sacramento 3
Seattle 3
Trieste 3
Asti 2
Bangalore 2
Fairfield 2
Helsinki 2
Jinan 2
Leipzig 2
San Mauro Torinese 2
Shaoxing 2
Shenyang 2
Tirana 2
Trecastagni 2
Winnipeg 2
Wuhan 2
Adliswil 1
Auburn Hills 1
Augusta 1
Bologna 1
Brno 1
Cardano 1
Cassano Magnago 1
Colle 1
Denia 1
Fuzhou 1
Gattico 1
Grafenhausen 1
Gunzenhausen 1
Hanover 1
Hebei 1
Henderson 1
Hyderabad 1
Kemerovo 1
Kocaeli 1
Köln 1
London 1
Modena 1
Monmouth Junction 1
Naaldwijk 1
Nanchang 1
Ngau Tau Kok 1
Nice 1
Palmetto 1
Perugia 1
Quarto D'asti 1
Redmond 1
Rome 1
Storrs Mansfield 1
Strasbourg 1
Taiyuan 1
Torino 1
Toronto 1
Treviso 1
Valdagno 1
Visp 1
Wenzhou 1
Zhengzhou 1
Totale 1.264
Nome #
Analysis of SF3B1 mutations in monoclonal B-cell lymphocytosis 109
The krüppel-like factor 2 transcription factor gene is recurrently mutated in splenic marginal zone lymphoma. 100
Diffuse large B-cell lymphoma genotyping on the liquid biopsy 99
Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia 75
Alteration of BIRC3 and multiple other NF-kB pathway genes in splenic marginal zone lymphoma 74
Different impact of NOTCH1 and SF3B1 mutations on the risk of chronic lymphocytic leukemia transformation to Richter syndrome 72
Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild type chronic lymphocytic leukemia 71
ASSOCIATION BETWEEN MOLECULAR LESIONS AND SPECIFIC B-CELL RECEPTOR SUBSETS IN CHRONIC LYMPHOCYTIC LEUKEMIA 69
MGA, a suppressor of MYC, is recurrently inactivated in high risk chronic lymphocytic leukemia 69
A variant of the LRP4 gene affects the risk of chronic lymphocytic leukaemia transformation to Richter syndrome 68
CLINICAL IMPACT OF SMALL SUBCLONES HARBORING NOTCH1, SF3B1 OR BIRC3 MUTATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA 68
CLINICAL IMPACT OF SMALL TP53 MUTATED SUBCLONES IN CHRONIC LYMPHOCYTIC LEUKEMIA 68
International Prognostic Score for Asymptomatic Early-stage Chronic Lymphocytic Leukemia 64
Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia 64
The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development 63
The genetics of nodal marginal zone lymphoma 63
Analysis of NOTCH1 mutations in monoclonal B cell lymphocytosis 62
Biology and treatment of Richter syndrome 62
Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness 61
Genome-wide DNA profiling better defines the prognosis of chronic lymphocytic leukaemia 60
GENETIC LESIONS ASSOCIATED WITH CHRONIC LYMPHOCYTIC LEUKEMIA CHEMO-REFRACTORINESS 56
MOLECULAR BASIS OF TARGET THERAPY FOR AGGRESSIVE B-CELL LYMPHOMA 55
Molecular history of Richter syndrome: Origin from a cell already present at the time of chronic lymphocytic leukemia diagnosis 55
The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation 54
KMT2D mutations and TP53 disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: a FIL study 54
MOLECULAR BASES OF CHRONIC LYMPHOCYTIC LEUKEMIA IN LIGHT OF NEW TREATMENTS 50
RICHTER SYNDROME: FROM MOLECULAR GENETIC TO THERAPEUTIC STRATEGIES 49
Liquid biopsy in lymphoma 46
Frequency and clinical relevance of coding and noncoding NOTCH1 mutations in early stage Binet A chronic lymphocytic leukemia patients 45
Methods for Measuring ctDNA in Lymphomas 39
null 37
Genetic and phenotypic attributes of splenic marginal zone lymphoma 33
Novel insights into the genetics and epigenetics of MALT lymphoma unveiled by next generation sequencing analyses 30
Circulating tumor DNA reveals genetics, clonal evolution and residual disease in classical Hodgkin lymphoma 23
XPO1 mutations identify early‐stage CLL characterized by shorter time to first treatment and enhanced BCR signalling 6
Totale 2.073
Categoria #
all - tutte 9.356
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.356


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020405 2 3 31 0 57 53 77 30 38 76 37 1
2020/2021243 37 10 33 2 35 5 33 11 34 10 33 0
2021/2022268 3 2 24 34 28 1 26 6 16 21 47 60
2022/2023648 36 27 58 7 53 64 20 38 298 2 24 21
2023/2024232 25 13 16 4 30 1 47 13 0 1 16 66
2024/20253 3 0 0 0 0 0 0 0 0 0 0 0
Totale 2.073